Myriad Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.97

-0.04 (-1.00%)

As of Sep 22, 2:55 PM ET ·

Analyst Consensus

Sell

Analysts

High

Coverage

Buy 2 13%

Hold 8 53%

Sell 5 33%

Price Target

Analyst Price Target +943.8% upside

Low Target $29.39

Average Target $41.44

High Target $63.29

Current Price $3.97

Current
$3.97

Target
$41.44

$29.39 $41.44 avg $63.29

Scenario Analysis

Bear Case

$29.39

640.3%

Low target

Base Case

$41.44

+943.8%

Avg target

Bull Case

$63.29

+1,494.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.59

-53.8% from high

52-Week Low

$2.74

+44.9% from low

Target vs 52W High

$41.44

+382.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.6%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.5%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%